The work will support the Million Veteran Program, which aims to study the link between genes and disease using a research cohort veterans and active military.

The partners signed a CRADA to develop biomarkers discovered by the Center for Prostate Disease Research for use in clinical diagnostic testing. 

NEW YORK (GenomeWeb) – PositiveID today announced an agreement with the US Special Operations Command Research, Development, and Acquisition Center to further develop military applications for the company's real-time PCR pathogen detection system, Firefly Dx.

NEW YORK (GenomeWeb News) – Biopharmaceutical firm Berg and the US Department of Defense today announced an agreement to discover biomarkers for prostate cancer and to develop more effective treatments for the disease.

NEW YORK (GenomeWeb News) – Vermillion has signed a cooperative research and development agreement, or CRADA, with the US Army Medical Research and Materiel Command for the evaluation of the OVA1 ovarian cancer diagnostic test, Vermillion announced today.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Agilent Technologies today said that it will collaborate with the US Food and Drug Administration on food testing applications.

ZyGem said today that it has signed a cooperative research and development agreement with the US Army Medical Research Institute of Infectious Diseases to develop simplified sample processing tools for biothreat agent detection.

Biomatrica and USAMRIID will collaborate to develop, test, validate, and eventually commercialize new formulations designed to stabilize clinical samples and biological agents at ambient conditions.

The startup will use its using next-generation sequencing-based technology for applications aimed at identifying biothreats.


An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.